Study explores risk factors for postoperative delirium

A new study aimed to investigate the risk factors and incidence rates of postoperative delirium in elderly and middle-aged patients with fractures.

Padcev, Keytruda’s new survival data; Seraxis raises $10M for diabetes cell therapy

Padcev, Keytruda’s confirmatory win: Astellas and Seagen said Friday that Padcev and Merck’s Keytruda helped certain bladder cancer patients live longer than chemotherapy in a

September 23, 2023

Absci and MSK Collaborate on Generative AI Drug Discovery

What You Should Know: – Absci Corporation, a leader in generative AI drug creation, today announced a strategic collaboration with Memorial Sloan Kettering Cancer Center

August 13, 2024

Clearmind Medicine to Present at the 8th Annual Dawson James Conference on October 12th – Psychedelic Alpha

Tel Aviv, Israel / Vancouver, Canada, Oct. 05, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the “company”), a

October 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.